Your browser doesn't support javascript.
loading
PLK1 Inhibition Sensitizes Breast Cancer Cells to Radiation via Suppressing Autophagy.
Wang, Baiyao; Huang, Xiaoting; Liang, Huiping; Yang, Hongli; Guo, Zhaoze; Ai, Meiling; Zhang, Jian; Khan, Muhammad; Tian, Yunhong; Sun, Quanquan; Mao, Zixu; Zheng, Ronghui; Yuan, Yawei.
Afiliación
  • Wang B; Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China.
  • Huang X; Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China.
  • Liang H; Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China.
  • Yang H; Department of Radiation Oncology, Shenzhen People's Hospital, Shenzhen, Guangdong Province, People's Republic of China.
  • Guo Z; Breast Center, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, People's Republic of China.
  • Ai M; Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China.
  • Zhang J; Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China.
  • Khan M; Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China.
  • Tian Y; Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China.
  • Sun Q; Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang Province, People's Republic of China.
  • Mao Z; Department of Pharmacology and Chemical Biology, School of Medicine, Emory University, Atlanta, Georgia.
  • Zheng R; Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China.
  • Yuan Y; Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China. Electronic address: yuanyawei@gzhmu.edu.cn.
Int J Radiat Oncol Biol Phys ; 110(4): 1234-1247, 2021 07 15.
Article en En | MEDLINE | ID: mdl-33621661
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fármacos Sensibilizantes a Radiaciones / Tolerancia a Radiación / Autofagia / Neoplasias de la Mama / Proteínas Proto-Oncogénicas / Proteínas Serina-Treonina Quinasas / Proteínas de Ciclo Celular / Inhibidores de Proteínas Quinasas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fármacos Sensibilizantes a Radiaciones / Tolerancia a Radiación / Autofagia / Neoplasias de la Mama / Proteínas Proto-Oncogénicas / Proteínas Serina-Treonina Quinasas / Proteínas de Ciclo Celular / Inhibidores de Proteínas Quinasas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos